Efficacy of Baricitinib in the Treatment of Chilblains Associated With Aicardi-Goutières Syndrome, a Type I Interferonopathy

2019-05-01

Arthritis and Rheumatology , Volume 71 - Issue 5 p. 829- 831

Additional Metadata
Persistent URL	doi.org/10.1002/art.40805, hdl.handle.net/1765/118340
Journal	Arthritis and Rheumatology
Organisation	Erasmus MC: University Medical Center Rotterdam
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Meesilpavikkai, K., Dik, W., Schrijver, B., van Helden-Meeuwsen, C., Versnel, M., van Hagen, M., … Dalm, V. (2019). Efficacy of Baricitinib in the Treatment of Chilblains Associated With Aicardi-Goutières Syndrome, a Type I Interferonopathy. Arthritis and Rheumatology, 71(5), 829–831. doi:10.1002/art.40805

Additional Files
1-s2.0-S0091674918305128-main.pdf Final Version , 1mb
fimmu-08-00274.pdf Final Version , 3mb

Publication